Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insiders Buying Shares Of Kennedy-Wilson Holdings Inc. (KW), Endurance Specialty Holdings Ltd. (ENH), Selling Fabrinet (FN)

Page 1 of 2

Generally, corporate insiders have all the knowledge about their investments that could turn an average investor into a “successful” one. It’s commonly known that corporate insiders possess a thorough knowledge and understanding of their companies and the industries they are operating in. Therefore, it does make perfect sense to track and examine insider trading activity, as it might provide useful insights into the prospects of different companies. In the following article, we will analyze the recent insider trading activity at three such companies: Kennedy-Wilson Holdings Inc. (NYSE:KW), Endurance Specialty Holdings Ltd. (NYSE:ENH) and Fabrinet (NYSE:FN). The first two companies saw insiders buy shares of their stock yesterday, whereas the latter company had a large volume of insider selling on the same day.

Insider Trading 3

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned 118% over the ensuing 35 months, outperforming the S&P 500 Index by 60 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Let’s start by looking into the insider activity at Kennedy-Wilson Holdings Inc. (NYSE:KW), which saw three different insiders purchase shares yesterday. To begin with, Stanley R. Zax, who has been acting as Independent Director at Kennedy-Wilson since 2010, acquired 19,800 shares at $22.18 each. Following the transaction, Zax now has a total stake of 169,800 shares. Furthermore, Matthew Windisch, an Executive Vice President at the company, added 5,000 shares at a price of $22.98 per share to his holding that now consists of 493,020 shares. Let’s not forget to mention that the company’s Chief Financial Officer, Justin Enbody, also purchased 2,500 shares at $22.32 apiece and boosted his stake to 241,392 shares. The shares of Kennedy-Wilson, a real estate investment and services company, are down by 9% year-to-date, mainly owning to the stock’s recent slump suffered since mid-August. Reportedly, Kennedy-Wilson Holdings acquired 720,000 additional shares of Kennedy-Wilson Europe Real Estate plc (LSE:KWE) between August 17 and August 18, amassing a 17.7% stake in the company. Hence, it seems that the U.S.-based company is increasing its exposure to the European markets in an attempt to diversify its risk. Meanwhile, Prem Watsa’s Fairfax Financial Holdings, the largest shareholder in Kennedy-Wilson Holdings Inc. (NYSE:KW) within our database, boosted its stake in the company to 8.95 million shares during the second quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!